JACC Impact Factor

The first signal is flagship status. JACC is one of the central broad-readership journals in clinical cardiology.

The second signal is durability. The five-year JIF of 24.2 is above the current JIF, which suggests strong papers continue to draw attention beyond the initial window.

The third signal is normalized strength. The JCI of 5.06 is extremely strong for a large and diverse cardiology category.

The fourth signal is cleanliness. The JIF without self-cites is 21.3, which is close to the headline number.

The practical read is that this is not just a high-impact cardiology journal. It is a flagship broad clinical cardiology owner with a demanding first editorial screen.

The JCR row above is the authoritative impact factor on this page. For the longer directional view, the table below uses the open Scopus-based impact score series as a trend proxy.

Directionally, the open citation signal is up from 8.22 in 2023 to 9.29 in 2024. The better interpretation is continued strength after a period of normalization across cardiovascular publishing.

The common mistake is to treat JACC as a generic "top cardiology" option.

That is too broad to guide submission well. JACC is selective about papers with clear and wide cardiology consequence. Many strong cardiovascular manuscripts do not have that exact shape.

Papers often miss here when they are:

• too narrow for a broad cardiology audience
• stronger as a subspecialty cardiology story
• technically good but with a soft practice consequence
• more mechanistic or translational than clinical in the main read

The number says the journal is elite. It does not say the paper belongs in the flagship rather than the wider JACC family or another cardiology owner.

In our pre-submission review work with manuscripts targeting JACC, three patterns show up repeatedly.

The paper is too narrow for the flagship. Good subspecialty work often belongs in the JACC family, but not always in the main journal.

The practical consequence is not strong enough. Editors want to see how the study changes cardiovascular thinking, not only that it adds another data point.

The package still feels one step short. Strong ideas can still miss when the evidence package, figure architecture, or abstract does not look fully flagship-ready.

If that sounds familiar, a JACC submission readiness review is usually more useful than another incremental wording pass.

The official ACC author-facing materials add a useful non-JCR signal: JACC promises first decision notification in 3 weeks or less and positions the journal around broad cardiovascular relevance for a flagship readership.

That matters because it shows why the metric is commercially meaningful. JACC is not only highly cited. It also moves fast at the editorial front door and expects the audience case to be visible early.

The impact factor does not tell you whether the paper is broad enough, whether the practical consequence is strong enough, or whether the best readership is actually a JACC specialty title or another cardiology journal.

Those are the real editorial questions.